<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K/A
(AMENDMENT NO. 2)
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) November 19, 1996
------------------------
EuroMed, Inc.
-------------------------------------------------------
(Exact name of registrant as specified in its charter)
Nevada 0-27720 88-031770
---------- ----------- -------------------
(State or other jurisdiction (Commission (IRS Employer
of incorporation File Number) Identification No.)
Wilhelminakanaal Noord 6, NL 4902VR Oosterhout, The Netherlands
- --------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code 011-31-16-203-7440
-------------------------
<PAGE> 2
Reference is made to the Current Report on Form 8-K filed by the Company on
November 26, 1996 (the "Form 8-K"). The Form 8-K was amended in its entirety by
the Current Report on Form 8-K/A (Amendment No. 1) filed on December 12, 1996
and is being further amended by the following:
ITEM 4. CHANGES IN REGISTRANT'S CERTIFYING ACCOUNTANT.
On November 19, 1996, KPMG Accountants N.V. ("KPMG") resigned as
EuroMed, Inc.'s independent public accountant. No report of KPMG for EuroMed
has contained an adverse opinion or a disclaimer of opinion, or was qualified
or modified as to uncertainty, audit scope, or accounting principles. There
have been no disagreements between KPMG and EuroMed as described in Item
304(a)(1)(iv) of Regulation S-K or events of the kind set forth in Item
304(a)(1)(v) of Regulation S- K.
EuroMed provided KPMG with the above disclosures prior to filing the
Form 8-K with the Commission. KPMG responded to the above disclosures by
stating that they resigned as principal accountants for EuroMed because they
believe that the current internal control structure of EuroMed is not adequate
to develop reliable financial statements. KPMG did not disclose to EuroMed
specific concerns or problems. EuroMed has requested that KPMG provide it with
such information.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS.
(c) Exhibits
Exhibit No. Description
----------- -----------
16 Letter Regarding Change in Principle
Accountant by KPMG Accountants (1)
- ---------------------------------
(1) Previously filed.
<PAGE> 3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
EUROMED, INC.
Date: January 3, 1997 By: /s/ Robert A. Shuey, III
------------------------------------
Robert A. Shuey, III
Co-Chief Executive Officer
3
